Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TP53TG3 Inhibitors

TP53TG3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the TP53TG3 protein, a component involved in key cellular functions. These inhibitors typically operate by binding to the active site of the TP53TG3 protein, blocking the interaction between the protein and its natural substrates or ligands. By occupying this site, TP53TG3 inhibitors prevent the protein from performing its normal role in biological processes, effectively disrupting its function. In some cases, these inhibitors can also act through an allosteric mechanism, where they bind to regions of the protein away from the active site, inducing conformational changes that impair the protein's functionality. The binding of TP53TG3 inhibitors is mediated by a range of non-covalent forces, such as hydrogen bonds, van der Waals interactions, hydrophobic contacts, and electrostatic interactions, which together stabilize the inhibitor-protein complex and enhance the inhibition process.

The structural diversity of TP53TG3 inhibitors is an essential feature, allowing for tailored interactions with the specific binding pockets of the TP53TG3 protein. These inhibitors often incorporate functional groups such as hydroxyl, amine, or carboxyl groups that facilitate hydrogen bonding with amino acid residues within the protein's active site. Additionally, hydrophobic interactions between non-polar regions of the inhibitor and the protein can enhance binding affinity. Many TP53TG3 inhibitors feature aromatic rings or heterocyclic structures, which contribute to the molecular stability and facilitate π-π stacking interactions with the protein's binding site. Physicochemical properties such as molecular weight, polarity, lipophilicity, and solubility are carefully optimized during the design of these inhibitors to ensure effective binding, stability, and functionality in different biological environments. By balancing hydrophilic and hydrophobic regions within the inhibitor, TP53TG3 inhibitors are fine-tuned to interact with both polar and non-polar regions of the protein, ensuring efficient inhibition under diverse conditions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Glycine anhydride

106-57-0sc-257563
sc-257563A
25 g
100 g
$59.00
$154.00
(0)

Known to deactivate the DNA-binding activity of p53, which could lead to reduced TP53TG3 expression if it's transcriptionally regulated by p53.

Phenothiazine

92-84-2sc-250686
sc-250686A
50 g
250 g
$23.00
$43.00
(0)

This compound deactivates p53's DNA-binding activity. This can impact TP53TG3 if its expression is regulated by p53's binding to its promoter region.

MIRA-1

72835-26-8sc-204087
sc-204087A
10 mg
50 mg
$116.00
$443.00
1
(1)

Restores wild-type conformation to mutant p53, but can also reduce the activity of wild-type p53. Potential reduced expression of TP53TG3 due to decreased p53 activity.

Chrysophanol

481-74-3sc-205631
sc-205631A
25 mg
100 mg
$72.00
$260.00
1
(1)

Inhibits p53 by hampering its DNA-binding activity. Reduced p53 action can lead to decreased TP53TG3 transcription if it's regulated by p53.

p53 Activator III, RITA

213261-59-7sc-202753
sc-202753A
sc-202753B
sc-202753C
1 mg
10 mg
100 mg
500 mg
$110.00
$268.00
$1533.00
$5103.00
9
(1)

Binds to p53 and prevents its association with MDM2, a primary negative regulator. However, in some contexts, it may also suppress p53's transcriptional activity, impacting TP53TG3 expression.

NSC 319726

71555-25-4sc-477736
10 mg
$159.00
(0)

Inhibits p53 by impairing its DNA-binding activity. TP53TG3 expression might be hindered if it's transcriptionally regulated by p53.

PRIMA-1MET

5291-32-7sc-361295
sc-361295A
10 mg
25 mg
$150.00
$319.00
5
(1)

Primarily restores mutant p53 to its wild-type conformation but can influence wild-type p53 as well. The expression of TP53TG3 might be affected indirectly through modulated p53 activity.